Novartis
Basel, Switzerland
East Hanover, New Jersey, United States
with other locations globally
United States
Website: https://www.novartis.com/
2125 articles with Novartis
-
FDA Advisory Committee Recommends Approval Of Novartis Pharmaceuticals Corporation's Exelon(R) (rivastigmine tartrate) In The Treatment Of Dementia Associated With Parkinson's Disease
5/18/2006
-
Novartis Pharmaceuticals Corporation Announces Efficacy Data On New Investigational High Blood Pressure Therapies At The American Society of Hypertension Annual Meeting
5/17/2006
-
Novartis Pharmaceuticals Corporation Drug Works For Parkinson's Says FDA Staffer
5/16/2006
-
FDA Approves Higher Dose Formulations Of Novartis Pharmaceuticals Corporation's Diovan HCT(R) For Treatment Of High Blood Pressure
5/1/2006
-
Novartis Pharmaceuticals Corporation Release: New Drug Application (NDA) For Rasilez(R) (Aliskiren), An Innovative Oral Renin Inhibitor To Treat High Blood Pressure, Accepted For Review By The US FDA
4/20/2006
-
Novartis Pharmaceuticals Corporation Completes Submissions In US And Europe For Gleevec(R) As Treatment For Four Rare Types Of Cancer
4/10/2006
-
Emisphere Technologies, Inc. Announces Oral PTH License Agreement
3/8/2006
-
Infinity Pharmaceuticals, Inc. Announces Major Drug Discovery, Development And Commercialization Alliance In Oncology; Worth Up To $400 Million
3/6/2006
-
Novartis Pharmaceuticals Corporation Release: Single-Dose Famvir(R) Treatment Found To Accelerate Healing Time Of Cold Sore Outbreaks
3/3/2006
-
Idenix Pharmaceuticals, Inc. And Novartis Pharmaceuticals Corporation Announce New Drug Application Submitted To The U.S. Novartis Pharmaceuticals Corporation For Telbivudine For The Treatment Of Chronic Hepatitis B
1/3/2006
-
Novartis Pharmaceuticals Corporation's Femara(R) Receives US Approval As Initial Therapy For Postmenopausal Women With Early Breast Cancer After Surgery
12/29/2005
-
Novartis Pharmaceuticals Corporation Release: Single-Day Famvir Treatment Found To Shorten The Duration Of Recurrent Genital Herpes Outbreaks
12/19/2005
-
Stopping Tamoxifen May Help Breast Cancer
12/12/2005
-
Novartis Pharmaceuticals Corporation Release: More Than 90% Of Patients Taking Gleevec(R) For A Form Of Chronic Myeloid Leukemia (CML) Alive After 4-1/2 Years In Landmark Study
12/12/2005
-
Novartis Pharmaceuticals Corporation And Astex Therapeutics Ink $520 Million Cancer Drug Deal
12/6/2005
-
Novartis Pharmaceuticals Corporation Release: NAVIGATOR Data Presented At American Heart Association's Scientific Sessions Provide New Insights About Cardiovascular And Diabetes Risk
11/16/2005
-
Novartis Pharmaceuticals Corporation Release: GLOBE Study Demonstrates Telbivudine Provides Significantly Greater Response On Antiviral Measures Vs. Lamivudine In Patients With Chronic Hepatitis B, The 10th Leading Cause Of Death Worldwide
11/14/2005
-
Idenix Pharmaceuticals, Inc. Release: GLOBE Study Demonstrates Telbivudine Provides Significantly Greater Response On Antiviral Measures Vs. Lamivudine In Patients With Chronic Hepatitis B, The 10th Leading Cause Of Death Worldwide
11/14/2005
-
Novartis AGĀ (NVS) Paying US$5.1 Billion For Rest Of Shares In Chiron Corporation
10/31/2005
-
FDA Cautions Doctors On Eczema Treatment
3/11/2005